STOCK TITAN

Avantor Stock Price, News & Analysis

AVTR NYSE

Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.

Avantor (NYSE: AVTR) delivers essential materials and technologies powering breakthroughs in life sciences and advanced industries. This news hub provides investors and professionals with direct access to official announcements, including product innovations, financial results, and strategic partnerships shaping the future of bioprocessing and semiconductor manufacturing.

Track critical updates across Avantor's core operations: earnings disclosures detailing performance in pharmaceutical solutions, regulatory filings impacting global supply chains, and advancements in sustainable production methods like their viral vector processing systems. Discover how developments in brands like J.T. Baker and Macron Fine Chemicals influence research and manufacturing efficiency worldwide.

Our curated news collection serves as a decision-making tool for monitoring Avantor's role in enabling scientific progress across 180+ countries. Bookmark this page for real-time insights into leadership changes, facility expansions, and emerging applications in gene therapy support systems.

Rhea-AI Summary

Avantor announced the pricing of an underwritten offering of 20,833,334 shares of its common stock at $42.00 per share. The offering includes a 30-day option for underwriters to purchase an additional 2,976,190 shares. Proceeds will primarily finance the acquisition of Masterflex from Antylia Scientific and may also support general corporate purposes. The offering is set to close on September 16, 2021, pending customary conditions. Goldman Sachs, Citigroup, and BofA Securities are among the joint book-running managers for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
-
Rhea-AI Summary

Avantor announced plans to offer $750 million of common stock in an underwritten offering, related to a pending acquisition of the Masterflex bioprocessing business. The proceeds will also support debt financing. Underwriters may purchase additional shares within 30 days. The company aims to use net proceeds primarily for the acquisition, or for general corporate purposes if not completed. The offering's managers include Goldman Sachs, Citigroup, and BofA Securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) announced a definitive agreement to acquire Masterflex bioprocessing business from Antylia Scientific for $2.9 billion, netting $2.7 billion after tax benefits. Masterflex, based in Illinois, focuses on peristaltic pumps and single-use fluid transfer technologies, generating approximately $300 million in estimated 2022 revenues. This acquisition aims to enhance Avantor's biopharma offerings, contributing to revenue growth and margin improvement. Completion is expected in Q4 2021, subject to regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.14%
Tags
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) announced a multi-year investment to enhance its global hydration capabilities, completing a significant facility expansion in Gliwice, Poland, and initiating further expansion in Aurora, Ohio, projected to finish by mid-2022. This investment aims to support the biopharmaceutical industry's increasing demand for biologics by outsourcing buffer preparation, which can streamline workflows and accelerate therapy production. The expanded facilities will improve Avantor's ability to offer WFI-quality water buffer manufacturing, enhancing support for biopharma manufacturers globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
none
-
News
Rhea-AI Summary

Avantor, a global leader in mission-critical products for various industries, announced a virtual investor day scheduled for September 9, 2021, at 9:00 a.m. EDT. The event will be accessible via webcast on their official website, where a replay will also be available post-event. Avantor serves over 225,000 customer locations globally, impacting research and production across biopharma, healthcare, education, and advanced technology sectors. The company emphasizes forward-looking statements, cautioning that these may involve risks and uncertainties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
conferences
-
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) reported robust financial results for Q2 2021, with net sales of $1.86 billion, up 25.7% year-on-year. Net income surged 162.1% to $157.8 million. The company achieved 34.2% growth in Adjusted EBITDA to $366.6 million, with a margin expansion of 125 basis points. Despite two acquisitions, Ritter GMBH and RIM Bio, having no significant impact on quarterly results, the company raised its full-year guidance, reflecting confidence in ongoing momentum across various markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
none
-
Rhea-AI Summary

Avantor (NYSE: AVTR) announced a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, translating to a rate of 1.560%. This dividend is payable on August 16, 2021 to shareholders of record as of August 1, 2021. As a leading global provider of essential products and services across life sciences and technology sectors, Avantor's substantial footprint serves over 225,000 customer locations in more than 180 countries, underscoring its influence in critical research and development activities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
dividends
-
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR) has announced a change in the schedule for its second quarter 2021 earnings release. The financial results will now be disclosed after market close on July 29, 2021, followed by a conference call on July 30, 2021, at 7:30 a.m. EDT. Interested participants can join the call by dialing (866) 211-4132 domestically or (647) 689-6615 internationally. A live webcast will be available on the company’s investor webpage, with a replay accessible until August 28, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
conferences earnings
Rhea-AI Summary

Avantor, Inc. (NYSE: AVTR), a global provider of essential products and services, will release its Q2 2021 financial results after market close on July 28, 2021. The company will host a conference call at 5:00 p.m. EDT to discuss these results. Interested participants can join via phone or through a live webcast on Avantor's investor website. The earnings press release and presentation will also be available. Avantor serves over 225,000 customer locations worldwide, emphasizing its significant role in the life sciences and advanced technologies sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
conferences earnings

FAQ

What is the current stock price of Avantor (AVTR)?

The current stock price of Avantor (AVTR) is $11.46 as of January 1, 2026.

What is the market cap of Avantor (AVTR)?

The market cap of Avantor (AVTR) is approximately 7.8B.
Avantor

NYSE:AVTR

AVTR Rankings

AVTR Stock Data

7.81B
657.57M
1.37%
106.68%
4.4%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR